ClearPoint Neuro, Inc.
CLPT
NASDAQ·Healthcare·Medical - Devices·Mkt cap $418.7M
$13.96
▼ -0.64%
P/E
-11.83
Mkt Cap
$418.7M
52-Wk Range
$8.27–$30.10
52-Week Range
$8.27 - $30.10
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 27.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary MRI-guided surgical platform with direct visualization capabilities
- Strategic partnerships with Boston Scientific, Philips, and leading academic medical centers
- Regulatory clearances and established clinical validation in neurosurgery
- Unique positioning in minimally invasive brain surgery market with limited direct competition
Bear Case
1 risk
- Average volatility.
Growth
Moderate growth ahead
Expanding deep brain stimulation market for Parkinson's disease and movement disorders
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Stable
+4.3% over 3m
Quality
Excellent
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying CLPT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 3, 2026
Reported EPS of -$0.38 vs -$0.29 consensus (-32.6% surprise). Revenue of $10.9M vs $12.7M expected (-14.6%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-32.6%
Revenue trend · last 8Q
—
+14%
+11%
+17%
+9%
+34%
+43%
+18%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$8.1M
$7.8M
$8.5M
$9.2M
$8.9M
$10.4M
$12.1M
$10.9M
Margins · last 8Q
Gross
63.6%
Operating
-94.2%
Profit
-104.2%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: B. Riley · Jun 18, 2026
vs Industry
How CLPT stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related